Pharma player’s move has supply chain resilience at its core
Consumer health company Opella has launched a $70 million production facility in Mexico.

BILLED AS not ‘just another factory opening’, it is said to be a strategic move to regionalise manufacturing for the Americas and create a dual-hub network with its main plant in Italy, seeking to de-risk the network.
Opella chief supply chain officer Rafik Amrane, says: “This new production line in Mexico is a crucial step forward in our broader mission to build a highly resilient, global manufacturing network. By increasing our production capacity and being closer to the markets we serve, we are fundamentally changing how we deliver care.”
The dual hubs are strategically positioned to absorb the projected double digit global market growth without disruption to existing operations.


